Literature DB >> 6273732

Production in B. subtilis of hepatitis B core antigen and a major antigen of foot and mouth disease virus.

K Hardy, S Stahl, H Küpper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273732     DOI: 10.1038/293481a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  Conversion of Glucose to 2-Keto-l-Gulonate, an Intermediate in l-Ascorbate Synthesis, by a Recombinant Strain of Erwinia citreus.

Authors:  J F Grindley; M A Payton; H van de Pol; K G Hardy
Journal:  Appl Environ Microbiol       Date:  1988-07       Impact factor: 4.792

2.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

3.  Use of the Bacillus subtilis subtilisin signal peptide for efficient secretion of TEM beta-lactamase during growth.

Authors:  S L Wong; F Kawamura; R H Doi
Journal:  J Bacteriol       Date:  1986-11       Impact factor: 3.490

4.  Expression of a chemically synthesized human alpha 1 interferon gene.

Authors:  E De Maeyer; D Skup; K S Prasad; J De Maeyer-Guignard; B Williams; P Meacock; G Sharpe; D Pioli; J Hennam; W Schuch; K Atherton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

5.  Direct expression of hepatitis B surface antigen gene in E. coli.

Authors:  Y Fujisawa; Y Ito; R Sasada; Y Ono; K Igarashi; R Marumoto; M Kikuchi; Y Sugino
Journal:  Nucleic Acids Res       Date:  1983-06-11       Impact factor: 16.971

6.  High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets.

Authors:  G Harth; B Y Lee; M A Horwitz
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  Use of the Escherichia coli lac repressor and operator to control gene expression in Bacillus subtilis.

Authors:  D G Yansura; D J Henner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons.

Authors:  A Miyanohara; T Imamura; M Araki; K Sugawara; N Ohtomo; K Matsubara
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

9.  Construction of plasmid cloning vectors for lactic streptococci which also replicate in Bacillus subtilis and Escherichia coli.

Authors:  J Kok; J M van der Vossen; G Venema
Journal:  Appl Environ Microbiol       Date:  1984-10       Impact factor: 4.792

10.  Expression in Bacillus subtilis of the gene for human urogastrone using synthetic ribosome binding sites.

Authors:  J I Flock; I Fotheringham; J Light; L Bell; R Derbyshire
Journal:  Mol Gen Genet       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.